Downloads: 1 | Views: 276 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Informative Article | Pharmacotherapeutics | India | Volume 11 Issue 6, June 2022 | Rating: 4.3 / 10
Will Dostarlimab Become the New Rectal Cancer Drug of Choice?
Motupalli Sankeerth Kumar, Ponnaluri Lalitha, Seelam Victor John Wilson
Abstract: Information on a recent clinical trial in the United States on a drug that has been shown to be nearly 100% effective against rectal cancer in the sample population.
Keywords: Dostarlimab, Rectal cancer, new drug of choice
Edition: Volume 11 Issue 6, June 2022,
Pages: 1369 - 1369